MA-BRIGHTCOVE
Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced Sistema Brasileiro de Televisão (SBT), one of Brazil's most prominent TV networks, has chosen Brightcove as its official streaming technology partner to power its new AVOD app, +SBT. The service is scheduled to launch in April. Selected for its Emmy Award-winning technology, Brightcove’s reliability, scalability, and security will help SBT stream content from its more than 100 broadcast stations directly to audiences throughout Brazil.
“SBT is one of the most well-known media organizations in Brazil. The launch of their new streaming service will be a significant step for the company and its viewers and a great example of how entertainment and content can merge with technology to reach bigger audiences,” said Marc DeBevoise, CEO of Brightcove. “Today’s consumers demand instant access to news and content, making streaming an integral part of any media organization’s strategy. By partnering with us, SBT will be able to provide a seamless in-app streaming experience to expand their reach with new audiences, deepen engagement, and further monetize their content.”
Brightcove’s work with SBT underlines the importance of having a trusted technology partner in the media and streaming industry. Consumer demand for high-quality streams continues to rise, and media companies are increasingly recognizing the need to partner with scalable and reliable technology leaders who can deliver superior and cost-effective solutions, tailored to grow their streaming businesses, revenue, and end-user experiences.
“As one of the most-watched TV networks in Brazil, we needed to find a reliable way to deliver a wide range of video content to our viewers, including popular TV shows, news programs, and events,” said Roberto Grosman, Chief Transformation Officer at SBT. “We found a valuable partner in Brightcove. With their robust streaming solutions, we can trust that our audiences will be able to consume high-quality and secure video streams. We’ll also be able to view first-party data analytics to adapt our content and streaming strategy accordingly.”
SBT joins a roster of media companies that rely on Brightcove to power their streaming capabilities, including AMC Networks, BBC Studios, Forbes, In the Black Network, NHL, SKY Mexico, The Academy of Motion Pictures and Sciences, The National Academy of Television Arts & Sciences, and Yahoo.
For more information, visit Brightcove.com.
About Sistema Brasileiro de Televisão (SBT)
On August 19, 1981, the Sistema Brasileiro de Televisão was inaugurated. Considered the Brazilian family channel, SBT reaches 200 million viewers and 69 million homes. It currently has 114 stations across the country, with 24 hours of diversified programming, with a share of 9.4% in Greater São Paulo and 8.4% in Brazil. The SBT complex has a total area of 230,000m² with 74,000m² of built area. It has eight studios, totaling an area of more than 4,400 m², and a scenographic city of 6,500 m². SBT is a consolidated success in auditorium programs, a reference in the production of content for children and young people. It has impartial and credible journalism, in addition to a strong digital presence with exclusive content.
Source: Kantar IBOPE Media - Instar Analytics - Household Data - SHR% Total Connected - Greater São Paulo and Metropolitan Regions (15 markets) - 24 hours - Jan to Jul/22 | SBT Coverage Atlas – Jul/22. |
About Brightcove, Inc.
Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow Brightcove on LinkedIn, X (Formerly Twitter), Facebook, Instagram, Threads, and YouTube. Visit Brightcove.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207031743/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press release
Ranks 125th Among 500 Companies Around the GlobeTop 10% in the Environmental Sector Among 3,000 Major Global Companies Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 10
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press release
Agreement Marks Significant Step Towards Increasing Italy’s Contribution to advancing Lunar Exploration ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom